Brief: ADMA Biologics Q2 Loss Per Share $0.25

ADMA Biologics

08/08/2019 12:16

Aug 8 (Reuters) - ADMA Biologics Inc  ADMA.O :
    * ADMA BIOLOGICS REPORTS SECOND QUARTER AND FIRST HALF 2019
FINANCIAL RESULTS
    * Q2 LOSS PER SHARE $0.25
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.29 -- REFINITIV IBES
DATA
    * Q2 REVENUE ROSE 41 PERCENT TO $6.6 MILLION
    * Q2 REVENUE ESTIMATE $3.3 MILLION -- REFINITIV IBES DATA
    * COMMERCIAL LAUNCHES AND SALES OF BIVIGAM® AND ASCENIV™ IN
SECOND
HALF OF 2019
    * WE EXPECT TO GENERATE ADDITIONAL REVENUE UNDER BPC
CONTRACT
DURING SECOND HALF OF 2019

Source text for Eikon:  ID:nGNXqb0Yj 
Further company coverage:  ADMA.O 

 ((Reuters.Briefs@thomsonreuters.com;))